Skip to content
HowShorted

DermTech, Inc. short interest in 2020

In 2020, DermTech, Inc.'s disclosed short interest ran from 0.71% of shares outstanding on 15 Jan 2020 to 5.94% on 31 Dec 2020, a change of +5.23 percentage points. The year's high was 5.94% on 31 Dec 2020 and its low 0.63% on 28 Feb 2020, averaging 1.76% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.72 days on 30 Apr 2020. Full history: DermTech, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for DermTech, Inc. in 2020

2020 in figures

Start of year
0.71% (15 Jan 2020)
End of year
5.94% (31 Dec 2020)
Change
+5.23 pp
High
5.94% (31 Dec 2020)
Low
0.63% (28 Feb 2020)
Average
1.76%
Highest days to cover
7.72 (30 Apr 2020)
SEC filings marked
8

Every report in 2020

DermTech, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20200.71%1.14
31 Jan 20200.71%1.52
14 Feb 20200.64%3.49
28 Feb 20200.63%2.37
13 Mar 20200.68%1.24results (8-K), 10-K filed
31 Mar 20201.45%4.22
15 Apr 20201.41%6.46
30 Apr 20201.31%7.72
15 May 20201.23%3.9810-Q filed, results (8-K)
29 May 20201.53%4.65
15 Jun 20201.01%1.63
30 Jun 20202.35%1.36
15 Jul 20202.32%4.16
31 Jul 20201.85%2.93
14 Aug 20201.39%2.4810-Q filed, results (8-K)
31 Aug 20201.23%2.05
15 Sep 20201.64%2.17
30 Sep 20201.76%3.14
15 Oct 20201.43%3.78
30 Oct 20201.38%2.66
13 Nov 20201.53%2.7410-Q filed, results (8-K)
30 Nov 20203.36%3.99
15 Dec 20204.87%3.74
31 Dec 20205.94%1.00

See also: DermTech, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.